BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18167620)

  • 1. The incidence of second primary invasive melanoma in Queensland, 1982-2003.
    McCaul KA; Fritschi L; Baade P; Coory M
    Cancer Causes Control; 2008 Jun; 19(5):451-8. PubMed ID: 18167620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
    Coory M; Baade P; Aitken J; Smithers M; McLeod GR; Ring I
    Cancer Causes Control; 2006 Feb; 17(1):21-7. PubMed ID: 16411049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of self-examination in the earliest diagnosis of multiple primary cutaneous melanomas: a report of 47 cases.
    Manganoni AM; Farisoglio C; Tucci G; Facchetti F; Calzavara Pinton PG
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1333-6. PubMed ID: 17958838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple primary melanomas: an analysis of cancer registry data from Victoria and New South Wales.
    Giles G; Staples M; McCredie M; Coates M
    Melanoma Res; 1995 Dec; 5(6):433-8. PubMed ID: 8589618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geographical variation of incidence of cutaneous melanoma in Queensland.
    Buettner PG; MacLennan R
    Aust J Rural Health; 2008 Oct; 16(5):269-77. PubMed ID: 18808484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of second primary malignancies in women with papillary thyroid cancer.
    Canchola AJ; Horn-Ross PL; Purdie DM
    Am J Epidemiol; 2006 Mar; 163(6):521-7. PubMed ID: 16421240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion?
    Whiteman DC; Bray CA; Siskind V; Green AC; Hole DJ; Mackie RM
    Eur J Cancer Prev; 2008 Jun; 17(3):243-50. PubMed ID: 18414196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A profile of invasive cutaneous malignant melanoma in Malta: 1993-2002.
    Aquilina S; Dalmas M; Calleja N; Gatt P; Scerri L
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):958-63. PubMed ID: 16922945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
    Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
    J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thick melanoma: the challenge persists.
    Murray CS; Stockton DL; Doherty VR
    Br J Dermatol; 2005 Jan; 152(1):104-9. PubMed ID: 15656809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evidence base for reconsidering current follow-up guidelines for patients with cutaneous melanoma less than 0.5 mm thick at diagnosis.
    Einwachter-Thompson J; MacKie RM
    Br J Dermatol; 2008 Aug; 159(2):337-41. PubMed ID: 18510665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient education and regular surveillance results in earlier diagnosis of second primary melanoma.
    Uliasz A; Lebwohl M
    Int J Dermatol; 2007 Jun; 46(6):575-7. PubMed ID: 17550554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
    Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
    JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries).
    Crocetti E; Guzzinati S; Paci E; Falcini F; Zanetti R; Vercelli M; Rashid I; De Lisi V; Russo A; Vitarelli S; Ferretti S; Mangone L; Cesaraccio R; Tumino R; Pannozzo F
    Melanoma Res; 2008 Jun; 18(3):230-4. PubMed ID: 18477899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of uveal melanoma in Europe.
    Virgili G; Gatta G; Ciccolallo L; Capocaccia R; Biggeri A; Crocetti E; Lutz JM; Paci E;
    Ophthalmology; 2007 Dec; 114(12):2309-15. PubMed ID: 17498805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary malignant melanoma of skin in four regions of New Zealand.
    Cooke K; McNoe B; Hursthouse M; Taylor R
    N Z Med J; 1992 Aug; 105(939):303-6. PubMed ID: 1501812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High constant incidence rates of second primary neoplasms.
    Levi F; Boffetta P; La Vecchia C
    Eur J Cancer Prev; 2008 Oct; 17(5):385-8. PubMed ID: 18714177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive cutaneous melanoma in The Netherlands, 1989-1990.
    Tersmette AC; Coebergh JW; Casparie-van Velsen IJ; Ruiter DJ; van der Rhee HJ; Welvaart K
    Eur J Cancer Prev; 1996 Feb; 5(1):69-74. PubMed ID: 8664813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989-2008.
    van der Leest RJ; Liu L; Coebergh JW; Neumann HA; Mooi WJ; Nijsten T; de Vries E
    Br J Dermatol; 2012 Dec; 167(6):1321-30. PubMed ID: 22759226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma and additional primary cancers.
    Retsas S; Mohith A; Bell J; Horwood N; Alexander H
    Melanoma Res; 2000 Apr; 10(2):145-52. PubMed ID: 10803715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.